Immunity Gone Viral
Authors:
- Sonali AjwaniSASonali Ajwani
- Brian G. WeinshenkerBWBrian G. Weinshenker
- Caterina GianniniCGCaterina Giannini
- Thomas M. HabermannTHThomas M. Habermann
- Pamela SkrabekPSPamela Skrabek
- Michel ToledanoMTMichel Toledano
- Susan E. HorsmanSHSusan E. Horsman
- Claudia Francesca LucchinettiCLClaudia Francesca Lucchinetti
- Eoin P. FlanaganEFEoin P. Flanagan
Open Access
- 1 July 2026
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 13 (4) , e200607
Abstract
Subacute cognitive decline and imbalance in aquaporin-4-antibody-seropositive neuromyelitis optica spectrum disorder (AQP4+NMOSD) treated with mycophenolate has a broad differential diagnosis, including cerebral involvement of AQP4+NMOSD, infections, or other complications of immunosuppression. In this article, we highlight the diagnostic and treatment approach in a patient with AQP4+NMOSD who developed multifocal brain lesions.Keywords
This publication has 20 references indexed in Scilit:
- Post-Transplantation Lymphoproliferative Disorders in AdultsNew England Journal of Medicine, 2018
- Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findingsMultiple Sclerosis Journal, 2017
- Spontaneous remission lasting more than a decade in untreated AQP4 antibody-positive NMOSDNeurology Neuroimmunology & Neuroinflammation, 2017
- Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usageOncotarget, 2015
- MRI characteristics of neuromyelitis optica spectrum disorderNeurology, 2015
- A Case Series of Primary Central Nervous System Posttransplantation Lymphoproliferative DisorderNeurosurgery, 2013
- Familial neuromyelitis opticaNeurology, 2010
- CNS aquaporin-4 autoimmunity in childrenNeurology, 2008
- EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetilNeuro-Oncology, 2007
- Prospective Registry‐Based Observational Cohort Study of the Long‐Term Risk of Malignancies in Renal Transplant Patients Treated with Mycophenolate MofetilAmerican Journal of Transplantation, 2005